Rapamycin-associated lymphoedema in an infant with Kasabach-Merritt phenomenon

被引：11

作者：

Boccara, O. ^{[1
,2
]}

Hadj-Rabia, S. ^{[1
,2
]}

Bourrat, E. ^{[3
]}

Coulombe, J. ^{[1
,2
]}

Bodemer, C. ^{[1
,2
]}

机构：

[1] Univ Paris 05, Sorbonne Paris Cite, Dept Dermatol, Inst Imagine,Hop Univ Necker Enfants Malad, 149 Rue Sevres, F-75105 Paris, France

[2] Univ Paris 05, Sorbonne Paris Cite, Reference Ctr Genodermatoses & Rare Skin Dis MAGE, Inst Imagine,Hop Univ Necker Enfants Malad, 149 Rue Sevres, F-75105 Paris, France

[3] Hop Robert Debre, Dept Gen Paediat, F-75019 Paris, France

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2016年 / 174卷 / 04期

关键词：

MAMMALIAN TARGET; SIROLIMUS; LYMPHANGIOGENESIS; INHIBITORS;

D O I：

10.1111/bjd.14290

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：933 / 934

页数：2

共 10 条

[1] Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis [J].

Bissler, John J. ;

McCormack, Francis X. ;

Young, Lisa R. ;

Elwing, Jean M. ;

Chuck, Gail ;

Leonard, Jennifer M. ;

Schmithorst, Vincent J. ;

Laor, Tal ;

Brody, Alan S. ;

Bean, Judy ;

Salisbury, Shelia ;

Franz, David N. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02) :140-151

[2] Sirolimus-associated lymphoedema: eight new cases and a proposed mechanism [J].

Desai, N. ;

Heenan, S. ;

Mortimer, P. S. .

BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (06) :1322-1326

[3] Sirolimus for the Treatment of Complicated Vascular Anomalies in Children [J].

Hammill, Adrienne M. ;

Wentzel, MarySue ;

Gupta, Anita ;

Nelson, Stephen ;

Lucky, Anne ;

Elluru, Ravi ;

Dasgupta, Roshni ;

Azizkhan, Richard G. ;

Adams, Denise M. .

PEDIATRIC BLOOD & CANCER, 2011, 57 (06) :1018-1024

[4] Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma [J].

Kai, Li ;

Wang, Zuopeng ;

Yao, Wei ;

Dong, Kuiran ;

Xiao, Xianmin .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (03) :471-476

[5] Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation [J].

Karpanen, Terhi ;

Wirzenius, Maria ;

Makinen, Taija ;

Veikkola, Tanja ;

Haisma, Hidde J. ;

Achen, Marc G. ;

Stacker, Steven A. ;

Pytowski, Bronislaw ;

Yla-Herttuala, Seppo ;

Alitalo, Kari .

AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (02) :708-718

[6] Sirolimus in pediatric renal transplantation [J].

Kasap, Belde .

PEDIATRIC TRANSPLANTATION, 2011, 15 (07) :673-685

[7] How to control lymphangiogenesis: A novel role for rapamycin [J].

Kerjaschki, D. .

KIDNEY INTERNATIONAL, 2007, 71 (08) :717-719

[8] Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis [J].

Kobayashi, Soichi ;

Kishimoto, Takashi ;

Kamata, Shigeyuki ;

Otsuka, Masayuki ;

Miyazaki, Masaru ;

Ishikura, Hiroshi .

CANCER SCIENCE, 2007, 98 (05) :726-733

[9] Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies [J].

Teachey, David T. ;

Grupp, Stephan A. ;

Brown, Valerie I. .

BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (05) :569-580

[10] Target of rapamycin inhibitors (Sirolimus and Everolimus) for primary immunosuppression of kidney transplant recipients: A systematic review and meta-analysis of randomized trials [J].

Webster, Angela C. ;

Lee, Vincent W. S. ;

Chapman, Jeremy R. ;

Craig, Jonathan C. .

TRANSPLANTATION, 2006, 81 (09) :1234-1248

← 1 →